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The aim of the study was to investigate compliance with long-term oxygen therapy (LTOT), the consumption of 
mobile oxygen and factors that might influence on these measures. 
The study included 182 patients with LTOT and 125 patients answered a questionnaire on daily activities. 
Information on arterial gas tension, lung function: and diagnosis was obtained from the medical file. Data on oxygen 
systems and the actual usage of oxygen were obtained from the oxygen suppliers. 
Seventy-six per cent of the patients had a concentrator and 35% had both stationary and mobile oxygen, Good 
compliance (use of oxygen > 15 h day - ‘) was seen in 65%. Of the tested factors, only mobile oxygen had an influence 
on the effective usage. Outdoor activity was reported in 65% of the patients. Only 48% of these patients had mobile 
units, while 21% of the home-bound patients had mobile units. Of the patients with mobile oxygen, only 39% used 
their mobile unit >2 h week ~ ‘. Poorer usage of stationary oxygen was observed in patients with outdoor activity 
(2.4 hours day - * less). Although only 16 (13%) patients reported a usage less than 15 h day-‘, the actual 
consumption was less than 15 h day - i in 29%. 
In conclusion, patients on LTOT tended to overestimate their oxygen usage. Acceptable compliance was observed 
in 65% of the patients. Only mobile oxygen had a significant impact on the overall compliance. As more patients had 
outdoor activities than expected, and as these activities had a negative impact on the usage of stationary oxygen, 
more attention must by paid on detecting outdoor activities. However; as fewer than half of the patients with 
outdoor activity and mobile oxygen used their mobile systems, there is a need for measures to improve compliance 
with mobile oxygen. Using lists referring to the actual usage and discussing the usage with the patients may improve 
the compliance and cost-benefit. 
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Long-term oxygen therapy (LTOT) improves survival in 
patients with chronic hypoxaemic chronic obstructive pul- 
monary disease (COPD) if oxygen is used at least 15 h per 
day (1,2). Yet, several studies have shown that compliance 
is poor, as only 50-80% of the patients use oxygen for that 
amount of time (3-5). 
As many patients with LTOT are mobile, the prescription 
of a mobile system could possibly improve compliance. 
Mobile oxygen is recommended to patients with outdoor 
activities of at least 2 h per week (6). Compliance for mobile 
oxygen has been poorly described. In the present study, in 
which pulmonary physicians prescribed LTOT, we investi- 
gated factors which might influence compliance with 
stationary and mobile oxygen, in particular outdoor 
activity. 
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Materials and Methods 
From 1 November 1994 to 31 July 1995, we studied 182 
patients with LTOT. Data on outdoor activity were 
obtained from 125 patients, who answered a questionnaire 
(Fig. 1). The patients were started on LTOT at the 
Pulmonary Department, Bispebjerg Hospital, which is a 
University Hospital in Copenhagen, serving about 370 000 
inhabitants. The patients were at least 18 years old and 
received LTOT for chronic hypoxaemia from pulmonary 
disease. Diagnosis, arterial gas tension (optimal), use of 
tobacco and body mass index @MI) were obtained from 
the patients’ medical files. Patients were asked about out- 
door activity, consumption of oxygen, smoking, weight, 
height and WHO performance score (l-5: highest score 
related to poor activity) (7) (Table 1). Data on oxygen 
systems delivered and the actual usage of oxygen between 
November 1994 and September 1995 were obtained from 
the oxygen suppliers. Hours were taken from the oxygen 
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Inconclusive reply to outdoor activity .-” 
Study group with 
information on 
outdoor activity 
(n = 125) 
FIG. 1. Flow chart of patient recruitment. 
TABLE 1. Questionnaire on outdoor activity and usage of 
oxygen 
(1) Do you leave home? 
(a) Yes, with oxygen 
(b) Yes, without oxygen 
(cl No 
(2) How many hours per day do you use oxygen? 
concentrator meter readings and calculated from the 
delivered oxygen cylinders. Liquid oxygen was not available 
before August 1995, and none of the included patients was 
receiving liquid oxygen at the time of the study. Mobile 
oxygen (cylinders of 2-5 litres) was prescribed as preference 
if the patient was involved in outdoor activities. The 
decision between delivering a concentrator or a stationary 
cylinder was most often taken by the oxygen suppliers. As a 
concentrator is less expensive than cylinders when the usage 
is high, we expect the usage of oxygen to have affected this 
decision. 
STATISTICS 
Data analysis and descriptive statistics were performed with 
SPSS for Windows Ver. 8.0 (SPSS, Inc., Chicago, U.S.A.). 
All continuous and ordinal variables expressed as medians 
and ranges, and binomial variables are expressed as a 
percentage. The chi-squared, two sample t- and Mann- 
Whitney U-tests were used as appropriate to compare 
differences between groups. Linear regression analysis was 
applied to investigate the relationship of actual usage of 
oxygen to usage according to the patient. A P-value x0.05 
was accepted as significant. 
Results 
CHARACTERISTICS OF PATIENTS 
Patient characteristics are given in Table 2. A questionnaire 
was filled out by 128 (70%) of the patients. Non-responders 
differed from the responders by a worse 3-month survival 
rate, 67 vs. 94% (P<O.OOl), while there was no difference in 
the variables listed in Table 1. Of the 182 patients, the 
majority were women and had COPD. A BMI < 17 kg rn-’ 
was seen in lo%, and 5% had a BMI >30 kg m - 2. Patients 
had been on LTOT for an average of 11.7 months. Without 
oxygen, 89% of the patients had a PO, ~8.0 kPa, 74% a 
PO, ~7.3 kPa, and 53% of the patients had a X0, 
>6.5 kPa. With oxygen, 62% of the patients had a PO, 
>8.0 kPa. Generally, the level of activity was high, as 65% 
of the responders stated that they had outdoor activity, and 
according to the WHO performance questionnaire only 
40% stated being in bed during the day. 
PRESCRIPTION OF LTOT 
Seventy-six per cent of the patients used an oxygen concen- 
trator and 35% had both stationary oxygen and small 
cylinders during the study period. As expected, the patients 
with mobile oxygen were characterized by more frequent 
outdoor activities than those without mobile oxygen 
(P=O.O04). The vast majority of patients were prescribed a 
flow of 11 min- ‘, and only 7% were prescribed more than 
l.Slmin-‘. 
OVERALL COMPLIANCE WITH LTOT AND 
CONSUMPTION OF MOBILE OXYGEN 
Overall compliance with LTOT was acceptable, as 65% of 
the patients used oxygen > 15 h day- ‘. Usage of stationary 
oxygen was increased by 1.1 h day- i in patients with 
mobile oxygen. When this additional consumption was 
taken into account, the overall compliance was significantly 
higher in patients with mobile units (P=O.O16). Further- 
more increased compliance was seen in non-smokers 
(P=O.O04), and in patients who were hypoxaemic without 
oxygen (P=O.O15). However, in patients with a PO, ( - 0,) 
of less than 8.0 kPa, the level of hypoxaemia was not 
related to compliance. When we tested for an interaction 
between smoking status and mobile oxygen, only mobile 
oxygen had a positive impact. On the other hand, usage of 
mobile oxygen was small as 27% of the patients had used 
less than one cylinder (regarded as 0), and only 39% had a 
usage >2 h week- ‘. Correspondingly, only 58% of the 
patients with a mobile unit stated that they were using the 
oxygen outdoors. None of age, gender, oxygen flow, oxygen 
concentrator, arterial gastension with oxygen, diagnosis 
(COPD vs. other pulmonary disease) or activity score had 
an impact on the overall compliance or usage of mobile 
oxygen. 
MOBILE OXYGEN AND OUTDOOR ACTIVITY 
Just under half of the patients (39/81) who had outdoor 
activity were supplied with mobile oxygen, while 21% of the 
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TABLE 2. Characteristics of all patients (n= 182) and patients with data on outdoor activities (n= 125) 
Data on outdoor 
All patients activity available 
% Women 
Age in years: mean (SD) 
COPD (%) 
Other diseases* (%) 
PO, ( - 0,) in kPa: mean (SD) 
PCO, ( - 0,) in kPa: mean (SD) 
PO, (+ 0,) in kPa: mean (SD) 
PCO, (+ 0,) in kPa: mean (SD) 
BMI in kg m-‘: mean (SD) 
Current smokers (%) 
Mobile oxygen (%) 
Concentrator (%) 
Prescribed hours daily: mean (SD) 
Prescribed flow in 1 day - I: median (range) 
Oxygen used according to the patient in h day- 
Outdoor activity (%) 
Activity score (WHO): median (range) 
Duration of LTOT in months: median (range) 
FEV, (% of predicted value): mean (SD) 
65 70 
70.1 (9.6) 68.7 (9.2) 
84.1 82.4 
15.9 17.6 
66(1.2) 6.6 (1.1) 
6.8 (1.2) 6.8 (1.1) 
8.5 (1.6) 8.4 (1.3) 
7.4(1.5) 7.4(1.5) 
22.0(4.8) 22.1 (4.8) 
14.1 12 
35.2 38.4 
76.4 75.2 
17.4 (3.0) 17.4 (2.9) 
1.0 (0.5-3.0) 1 .o (0.553) 
‘: mean (SD) 17.7 (4.8) 17.7 (4-8) 
65 65 
2 (2-5) 2 (2-5) 
6.2 (O-l 12) 5.4 (O-l 12) 
29.1 (15.7) 28.7 (15.1) 
*Sequelae of tuberculosis or pulmonary embolism, kyphoscoliosis and lung fibrosis. 
TABLE 3. Characteristics of patients with and without mobile oxygen, and with and without outdoor 
activity 
Groups 
Patients (n) P value for 
differences between 
39 9 42 34 two groups 
O&M H&M O&S H&S (0 vs. H) 
Gender, female (%) 74 89 67 63 
Age (years) 67.7 64.1 67.2 72.9 
PO2 ( - 0,) @Pa) 6.47 6.47 6.81 6.52 
PO2 (+%I OW 8.53 8.32 8.32 8.34 
Use of (h day - ‘) oxygen 17.8 20.8 15.5 18.1 
Use >15 hday-’ (%) 74 89 48 74 
Use of mobile (h day - ‘) oxygen 1.32 1.13 0 0 
Use of mobile unit >2 h week ~ i (%) 49 22 0 0 
Stationary oxygen (h day - ‘) 16.5 19.6 15.5 18.1 
Activity score (WHO) 2.47 2.75 2.32 2.82 
n.s. 
* 
ns. 
n.s. 
11,s. 
n.s. 
n.s. 
n.s. 
* 
** 
Continuous and ordinal values are stated as means. 
0, Outdoor activity; H, home bound; MT mobile oxygen; S, stationary source without mobile 
oxygen. 
n.s.=Non-significant; *P<O.O5; **P<O.Ol. 
home-bound patients had a mobile unit (Table 3). Patients 
with outdoor activities were younger (P=O.O32) and had, as 
expected, a lower WHO activity score (i.e. higher activity) 
(P=O,OO6). Outdoor activity had a negative impact on the 
use of stationary oxygen (P=O.O3) and a tendency towards 
lower overall compliance (P=O,O69). 
USE OF OXYGEN ACCORDING TO THE 
PATIENT 
Only 13% of the patients stated that they used oxygen for 
less than 15 h day - I. The daily consumption rate matched 
the hours prescribed (P=O.Ol), with a weak trend of 
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exceeding the prescription. Of the patients who reported 
using oxygen for more than 15 h day - ‘, the actual 
usage was less than 15 h day- ’ in 29%. Patients who 
were overestimating their consumption did not differ 
significantly from the rest. 
Discussion 
COMPLIANCE WITH LTOT 
The NOTT and MRC studies (1,2) have shown that oxygen 
should be used for at least 15 h day- i to improve survival 
in patients with chronic hypoxaemia due to COPD (1,2), 
and thus LTOT ought to be prescribed for at least 
15 h day-’ in patients with chronic hypoxaemia. Patients 
with hypoxaemia caused by other pulmonary diseases 
such as as lung fibrosis, pneumoconiosis, sarcoidosis and 
sequelae from pulmonary tuberculosis are expected to have 
a benefit from LTOT. Although many patients reported 
that they used oxygen for fewer hours than prescribed, only 
13% stated a usage of less than 15 h day - I. This conflicted 
with the data from the oxygen supplier, which showed that 
34% of the patients should be regarded as non-compliant. 
In other studies, in which pulmonary physicians prescribed 
mostly LTOT, similar problems with compliance have been 
seen (3-5). 
In order to achieve good compliance, measures in 
addition to passing on correct information and prescribing 
LTOT are required. Asking the patient about usage brings 
poor compliance to light in only few patients. Therefore, 
one must consider referring to lists documenting the actual 
usage to aim at further improving compliance. 
FACTORS WITH IMPACT ON COMPLIANCE 
Walshaw et al. have shown that pulmonary physicians 
prescribe LTOT > 15 h day - ’ more often than general 
practitioners (8). As a pulmonary physician initiated LTOT 
in all our patients, we were able to focus on other factors 
which might influence compliance with LTOT. Better com- 
pliance was observed in patients with mobile oxygen. When 
the consumption of mobile oxygen is low (an average of 
1.1 h day- ‘), other factors, such as better instruction 
though more frequent visits by the oxygen company, may 
improve the overall compliance. Although the consumption 
of mobile oxygen was low, it had a positive impact on the 
overall compliance. No previous study has focused on 
the influence of outdoor activities and diseases causing 
hypoxaemia on compliance. We found that outdoor 
activities were correlated with a lower usage of stationary 
oxygen, while the overall compliance was only slightly 
decreased due to consumption of mobile oxygen. In our 
study, where only 29 patients had ‘other diseases’, the 
diagnosis had no impact on the compliance. However, this 
would need confirmation from a larger series. 
Smoking is a contraindication for LTOT, but 14% of our 
patients were still smoking. This is a recognized problem, as 
previous studies have shown that lo-50% of patients smoke 
(l-3,9-13). The real percentage is assumed to be even 
higher, as most studies rely on questionnaires and measured 
CO levels in exhaled air. In our study, after a multiple 
logistic analysis, smoking was found to have no impact on 
compliance. In 176 patients from London, the daily use of 
oxygen was lower in those of 75 years and older (10). 
However, age was not a predictor of compliance in our 
study. It also seems that sex has no influence on com- 
pliance. In most reported studies, the prescribed flow of 
oxygen was about 2 1 min ~ ‘, which is considerably higher 
than in our study (2,5,10). Although it is likely that a higher 
flow would increase the number of patients with PO, (+ 0,) 
>8.0 kPa compared to the 62% obtained with the present 
flow, it is uncertain whether it would have any influence on 
compliance. In our study, oxygen flow had no influence on 
compliance. A high flow is followed by more noise from the 
concentrator, shorter duration of the cylinders (and thus 
more home confinement due to more frequent deliveries) 
and drying of nasal mucosa. The influence of flow on 
compliance is still unclear. 
COMPLIANCE WITH MOBILE OXYGEN 
Patients who undergo outdoor activities should be supplied 
with mobile oxygen in order to increase the number of 
hours spent using oxygen and to enable the patient to be 
even more mobile. The extent of mobile oxygen varies 
between 20 and 67% between countries (10,14,15). In our 
study, 65% of the patients underwent outdoor activity, but 
only 48% of these were equipped with a mobile unit. 
Disappointingly, more than half of the patients with mobile 
oxygen had used it for less than 2 h week - ‘, and many of 
these patients were not leaving their homes. One explana- 
tion for this rather high number of patients could be that 
although small cylinders are often mounted on a stroller, 
they are difficult for weak patients to handle. When the 
patients had outdoor activity, the usage of stationary 
oxygen fell by a couple of hours, but this was partly 
compensated for by usage of mobile oxygen, which was 
very low. This is in accordance with previous studies 
reporting low usage of mobile oxygen (5,15). It is possible 
that transtracheal oxygen therapy improves overall com- 
pliance and the use of mobile oxygen, but this therapy has 
very restricted inclusion criteria, which are fulfilled by very 
few patients (16). It appears that liquid oxygen has not 
solved the problem of the low use of mobile oxygen, and 
small cylinders are still the most widely distributed mobile 
system (5,17,18). The weight of the mobile unit was often 
stated as the most important factor in affecting usage. 
Therefore, development of more portable units is urgently 
required. 
In conclusion 
Our study has shown that patients on LTOT tend to 
overestimate their oxygen usage. Compliance (effective 
usage) was acceptable in 65% of the patients and highest in 
those with mobile oxygen. As more patients had outdoor 
activities than expected by the prescribing pulmonary 
physician, and as these activities had a negative impact on 
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the usage of stationary oxygen more care must be taken to 
consider outdoor activities. However, as fewer than half of 
the patients with outdoor activity and mobile oxygen used 
their mobile systems, there is also a need for measures to 
improve mobile oxygen compliance. Furthermore, the use 
of lists documenting the actual usage of oxygen and discuss- 
ing usage with the patients may improve both compliance 
and cost-benefit. 
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